Afghanistan vs Madagascar: Access to anti-retroviral drugs, female
Afghanistan
38.0%
in 2024
Madagascar
39.0%
in 2024
Afghanistan rank
129th
Madagascar rank
128th
Access to anti-retroviral drugs, female over time
- Afghanistan
- Madagascar
How they compare
Madagascar currently reports 39.0% against 38.0% in Afghanistan, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Madagascar ahead.
Afghanistan ranks 129th and Madagascar ranks 128th of 141 countries.
Across the 3 decades both report, Afghanistan averaged higher in 2 and Madagascar in 1.
Head to head by decade
| Decade | Afghanistan | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 0.4% | 0.3% | Madagascar |
| 2010s | 17.6% | 4.5% | 13.1% | Afghanistan |
| 2020s | 33.8% | 24.6% | 9.2% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Afghanistan or Madagascar?
- Madagascar, at 39.0% against 38.0% in Afghanistan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Afghanistan and Madagascar?
- 1.0%, with Madagascar ahead.
- How many years of comparable data are there for Afghanistan and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Madagascar rank globally for access to anti-retroviral drugs, female?
- Afghanistan ranks 129th and Madagascar ranks 128th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.